We are making progress in our preparations to launch our study aimed at improving care for children with sickle cell anemia. The EPiTOMISE study will compare three malaria prevention drugs for reducing malaria morbidity, hospitalization and mortality in children with sickle cell disease. In malaria endemic areas, malaria is one of the major causes of death and severe disease in these children.
